This site is intended for health professionals only

Published on 23 November 2011

Share this story:
Twitter
LinkedIn
RELATED ARTICLES
Child schizophrenia drug approved
Six IBD Fellowships to Begin in 2011
Oncology portfolio
A new generation of drugs for schizophrenia
High remission rates with Actemra

Understanding compassionate-use programmes

teaser

 

Prof Paola Minghetti, PhD  

Professor of Pharmaceutical Sciences, Universit



Most read

1
User-friendly osteoporosis therapy launched
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
Merck agrees huge Vioxx settlement
4
Janssen-Cilag’s Stelara approved by NICE
5
Issues affecting access to orphan drugs in Europe



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:
Twitter
LinkedIn
RELATED ARTICLES
VTE prevention: How can pharmacists contribute?
ESMO drives EU-level action to tackle shortages of essential medicines
Sponsored: IV ibuprofen: A new option in multimodal analgesia
Tibotec submits application to US FDA for Intelence
Antiretroviral therapy: Issues, new drugs and challenges